Background: Cancer testis antigens (CTAs) are a class of immune-stimulating antigens often overexpressed in many types of cancers. The usage of the CTAs as immunotherapy targets have been widely investigated in different cancers including melanoma. hematological malignancies. and colorectal cancer. https://www.roneverhart.com/Gul-Rune/